Author:
Sadatmadani Seyedeh Fatemeh,Malakoutikhah Zahra,Mohaghegh Fatemeh,Peikar Mohammadsaleh,Saboktakin Mahdi
Subject
Pharmacology (medical),Pharmacology
Reference16 articles.
1. Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience;Brazzelli;Journal of the European Academy of Dermatology and Venereology,2013
2. Cutaneous adverse events of targeted therapies for hematolymphoid malignancies;Ransohoff;Clinical Lymphoma Myeloma and Leukemia,2017
3. Development of psoriasis in a patient with chronic myelogenous leukaemia during nilotinib treatment;Nagai;European Journal of Haematology,2013
4. Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate;Kaur;Indian Journal of Dermatology, Venereology and Leprology,2015
5. Development of Psoriasis Vulgaris in a Chronic Myeloid Leukemia Patient on Second-Generation Tyrosine Kinase Inhibitor Therapy;Thekkudan;J Leuk,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献